IGES Institut GmbH

About IGES Institut GmbH

The IGES Institute is one of the largest private research and consulting firms for infrastructure and health issues in Germany. IGES scientists provide comprehensive knowledge and tools for policymakers and administrators, as well as businesses and service providers, to enable them to make informed decisions. The focus is on issues of provision, quality, financing, and the design of competition for public goods such as the healthcare system, transport, and education. EXPERIENCE FROM MORE THAN 4,000 PROJECTS Since its founding in 1980, more than 4,000 projects have been completed. The IGES bases its work on high levels of expertise and methodological competence and offers broad access to its own data sources and those of other institutions in all areas of work. THE IGES GROUP - COMPANIES IN SIX COUNTRIES The IGES Institute is the core of the IGES Group. The IGES Group includes several specialized subsidiaries in six European countries that primarily offer services for international life science industries. These are CSG Clinische Studien Gesellschaft (for clinical research), IMC clinicon (research and consulting for hospitals), the companies AiM, Meditech Access (France), Device Access UK Ltd. (all Market Access and Reimbursement for medical technology) as well as SYNERGUS RWE (Sweden, Market Access strategies), HealthEcon (Switzerland), in France IGES France Pharma Consulting, in the UK IGES UK Pharma Consulting and as a partner Optimax Access Ltd. (UK and Netherlands, consulting services for European healthcare markets), FUB IGES (research and consulting for the housing industry and environmental planning). Together, the IGES Group employs more than 200 people.